NanoViricides Inc. (NNVC)

[Nanotoday]

I think the point he/she was trying to make is that they haven't yet started trying to demonstrate success in humans.

Which I guess I have to agree with. They haven't even started, the fact that they have put Flucide on hold for at least 12 months while they try and optimize the herpecide in order to take it to the FDA for Toxicology requirements should not be construed as a complete change of focus and restarting of the process from scratch. It should be seen as NOW they have a winner and NOW they have a clearer and shorter path to market.

Forget everything they said before about rabies, Dengue, HIV, Flu...THIS time it's different.

Oh, and you can ignore the Tox and clinical complications that ocular treatments trigger...this is topical and topical is easier and faster.

Sounds even more silly when I say it out loud.